Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV (PLWH)

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
75N95023R00071
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This competitive solicitation from the National Institutes of Health National Institute on Drug Abuse seeks data analysis services to investigate the effects of novel medications for alcohol and substance use disorders on HIV-related outcomes using the Veterans Aging Cohort Study. Offerors must have full access to the necessary data sources and an existing analysis pipeline. The agency will award a firm fixed-price purchase order for an initial period of twelve months, with the option to extend an additional four twelve-month periods. Proposals are due no later than September 1, 2023 by 2:00 PM EST and will be evaluated based on technical approach, key personnel qualifications, and price.

There is no set-aside designated for this procurement. The primary NAICS code is 541690 for other scientific and technical consulting services, with no identified incumbents or budget range provided. The contractor will provide data extraction, management, and analysis services to produce a report on the pharmacoepidemiological study. The period of performance is for twelve months initially and could extend up to four additional years through optional periods of performance. Place of performance will be at the contractor's facilities.

Notice text

This is a combined synopsis/solicitation for a commercial service prepared inaccordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 assupplemented with additional information included in this notice. This announcementconstitutes the only solicitation; proposals are being requested and a written solicitationwill not be issued.

The solicitation number is 75N95023R00071 and the solicitation is issued as a Requestfor Quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authorityof the FAR Part 13.5— Simplified Procedures for Certain Commercial Products andCommercial Services.; and FAR Part 12—Acquisition of Commercial Products andCommercial Services, and is not expected to exceed the dollar value authorized underFAR Part 13.5. A fixed-price type of purchase order is contemplated for this requirement.

The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) Number 2023-05, dated August 8, 2023.

The North American Industry Classification System (NAICS) code for this procurement is541690 – Other Scientific and Technical Consulting Services, and the small business sizestandard is $19,000,000 in revenue or less. This requirement shall be solicited using fulland open competitive procedures.

The Government requires the following Services

Data extraction, management, analysis, and report of a propensity-score matchedpharmacoepidemiological study of baclofen and spironolactone, prescribed for anyindication, on HIV- and ASUD-related outcomes in a general patient population and anaturalistic setting, using the Veterans Aging Cohort Study (VACS).

Please refer to Attachment 1 – Statement of Work for details and informationdescribing the specific requirements.

The Government anticipates award of a firm fixed-price purchase order for thisacquisition, and the contractor shall provide data analysis services for a period of twelve(12)months from the date of award, with four 12-month option periods.

Files

File Type Posted
RFP No. 75N95023R00071.pdf PDF

Notice history

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors